Company Overview
- Headquarters
- 220 Montgomery St, San Francisco CA
- Website
- tacerebio.com
- Employees
- 3
- Industry
- Materials/Manufacturing
Financials & Stats
Revenue
$10B
Who is Tacere Therapeutics
Tacere Therapeutics, Inc. is a privately held biotechnology company headquartered in San Francisco, California. Employing 20 to 49 individuals, the company focuses on the research and development of innovative treatments for critical infectious diseases. Tacere Therapeutics specializes in developing RNA interference (RNAi) therapeutics for a range of serious conditions, with a particular emphasis on Hepatitis C (HCV). Their expertise encompasses gene medicine and novel biologicals, allowing them to identify and advance promising RNAi-based treatment candidates. The company's proprietary skills in RNAi technology differentiate them within the field of infectious disease treatment. Tacere Therapeutics is dedicated to leveraging its scientific expertise to develop effective and groundbreaking therapies for patients facing serious health challenges. Interested parties can learn more about Tacere Therapeutics and its ongoing research by visiting the company's website at tacerebio.com.
Tacere Therapeutics Industry Tags
Companies Similar to Tacere Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Tacere Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 30 | Newtown, PA | 1998 | |
| 10M | 10 | Redwood City, CA | ||
| 10M | 8 | Houston, TX | 2011 | |
| 10M | 16 | Bethlehem, PA | 2005 | |
| 10M | Pittsburgh, PA |